Literature DB >> 19619856

Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein.

Kaori Inoue1, Takanobu Gotou, Hirokuni Kitajima, Seiichi Mizuno, Takeshi Nakazawa, Naoyuki Yamamoto.   

Abstract

Casein hydrolysate by Aspergillus oryzae protease has been developed to obtain two kinds of antihypertensive peptides, Val-Pro-Pro and Ile-Pro-Pro. In this study, casein miso paste was prepared by adding casein at various concentrations during miso paste fermentation in order to release angiotensin-I converting enzyme (ACE) inhibitory peptides. Increase of peptide concentration and ACE inhibitory activity in casein miso paste was observed and corresponded to the degradation of casein and soy bean proteins during fermentation for 7 days. ACE inhibitory activity of the casein miso paste was higher than that of the general (casein-free) miso paste after fermentation for 7 days. The levels of ACE inhibitory peptides, Val-Pro-Pro and Ile-Pro-Pro, were increased in the casein miso paste during the fermentation. Significant antihypertensive effects of casein miso paste compared to water and the general miso paste (P<0.05 and P<0.05) were confirmed in spontaneously hypertensive rats at a dosage of 1.8 g of the casein miso paste/kg of BW. Taken into account of minimum effective dosages of Val-Pro-Pro and Ile-Pro-Pro in previous clinical studies, these results suggest that casein miso paste might have the potential to control blood pressure in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619856     DOI: 10.1016/j.jbiosc.2009.03.007

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  6 in total

Review 1.  Dietary-Nutraceutical Properties of Oat Protein and Peptides.

Authors:  Hamad Rafique; Rui Dong; Xiaolong Wang; Aamina Alim; Rana Muhammad Aadil; Lu Li; Liang Zou; Xinzhong Hu
Journal:  Front Nutr       Date:  2022-07-05

2.  Pilot-scale production of soybean oligopeptides and antioxidant and antihypertensive effects in vitro and in vivo.

Authors:  Mu-Yi Cai; Rui-Zeng Gu; Chen-Yue Li; Yong Ma; Zhe Dong; Wen-Ying Liu; Zhen-Tao Jin; Jun Lu; Wei-Xue Yi
Journal:  J Food Sci Technol       Date:  2012-04-25       Impact factor: 2.701

3.  AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides.

Authors:  Ravi Kumar; Kumardeep Chaudhary; Minakshi Sharma; Gandharva Nagpal; Jagat Singh Chauhan; Sandeep Singh; Ankur Gautam; Gajendra P S Raghava
Journal:  Nucleic Acids Res       Date:  2014-11-11       Impact factor: 16.971

Review 4.  A systematic review to identify biomarkers of intake for fermented food products.

Authors:  Katherine J Li; Elske M Brouwer-Brolsma; Kathryn J Burton-Pimentel; Guy Vergères; Edith J M Feskens
Journal:  Genes Nutr       Date:  2021-04-21       Impact factor: 5.523

5.  Newly manufactured Marukome MK-34-1 miso with angiotensin-converting enzyme inhibitory activity and its antihypertensive effects in genetic hypertensive rat models.

Authors:  Hiroe Sakuyama Tomari; Misa Uchikawa; Aki Yamazaki; Satomi Hirabayashi; Shoko Yamakawa; Manabu Kitagawa; Minami Yamada; Seiki Itou; Tetsuro Yamamoto; Yoshio Uehara
Journal:  Hypertens Res       Date:  2019-01-10       Impact factor: 3.872

6.  Enzymatic hydrolysis and microbial fermentation: The most favorable biotechnological methods for the release of bioactive peptides.

Authors:  Dora Elisa Cruz-Casas; Cristóbal N Aguilar; Juan A Ascacio-Valdés; Raúl Rodríguez-Herrera; Mónica L Chávez-González; Adriana C Flores-Gallegos
Journal:  Food Chem (Oxf)       Date:  2021-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.